OTC · Medical - Diagnostics & Research

Global WholeHealth Partners Corporation (GWHP) Stock

$0.00 OTC: GWHP Healthcare

Global WholeHealth Partners Corporation, established in 2013 and based in San Clemente, California, is dedicated to the development and distribution of a diverse array of in-vitro diagnostic test kits across the United States. The company provides swift diagnostic solutions, including rapid assays for CoVid-19, whole blood Ebola, whole blood Zika, and whole blood tuberculosis (TB), among other tests.

Valuation

MetricValue
Price$0.00
Market Cap$1313
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.18
EPS (TTM)$-0.05
52-Week High$6.00
52-Week Low—
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE250.00%
ROA—
ROCE266.71%
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity-0.50
Current Ratio0.01

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$0$0$-4.0M$-4.0M$-4.0M
Net Profit$0$0$-4.0M$-9.0M$-5.0M
EPS$-0.02$0.00$-0.07$-0.14$-0.05
Op Margin——-1765.5%-8926.3%-56759.3%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$1.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$1.0M

Latest News

Kirkland tops North America M&A table in H1 Private Banker International · Jul 30, 2026 Meta stock sinks 10% on earnings miss, 'barely passable' quarter Yahoo Finance · Jul 30, 2026 Morgan Stanley Says Amazon, Microsoft, and Google's AI Spending Will Pay Off Big GuruFocus.com · Jul 30, 2026 RBC Raises Price Target on General Dynamics to $410 From $385, Keeps Sector Perform Rating MT Newswires · Jul 30, 2026 Tourmaline Oil Q2 Earnings Fall 65% YoY MT Newswires · Jul 30, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$0$0$-1.0M$-1.0M$-2.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$1.0M$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$-1.0M$-1.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.17
FCF Yield-149901.52%
Quick Ratio0.01
Interest Coverage-4.32
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EPRSQEPIRUS Biopharmaceuticals, Inc. $0.00 — — $1571 0.00%
GNRSThe Greenrose Holding Company Inc. $0.00 — 0.00 $1768 0.00%
MICRDMicron Solutions, Inc. $0.00 — 0.00 $317 0.00%
MLTOMEDirect Latino, Inc. $0.00 — — $1700 0.00%
MTEMMolecular Templates, Inc. $0.00 — 0.00 $658 0.00%

About Global WholeHealth Partners Corporation

Global WholeHealth Partners Corporation, established in 2013 and based in San Clemente, California, is dedicated to the development and distribution of a diverse array of in-vitro diagnostic test kits across the United States. The company provides swift diagnostic solutions, including rapid assays for CoVid-19, whole blood Ebola, whole blood Zika, and whole blood tuberculosis (TB), among other tests. These diagnostic tools are designed for wide accessibility, catering to both over-the-counter consumer purchases and professional point-of-care settings such as hospitals, physicians' offices, and various medical clinics. Their product line effectively identifies a multitude of diseases, encompassing infections like Ebola, Zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other conditions transmitted by vectors.

Global WholeHealth Partners Corporation (GWHP) stock trades at $0.00 with a market capitalization of $1313. The stock is valued at price-to-book of 0.00, price-to-sales of 0.18.

On profitability, Global WholeHealth Partners Corporation generates a return on equity (ROE) of 250.00% (not meaningful, as shareholders' equity is negative), return on capital employed of 266.71%.

Official website: gwhpcorp.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.